accession	comparison	comparisonsText
GSE107363	1	HobRAvsHob
GSE85761	1	EVvsCells
GSE89179	1	siCon_FOB_ObvssiCon_FOB_Und
GSE89179	2	siCHD1_FOB_ObvssiCon_FOB_Ob
GSE89179	3	siCon_MSC_AdvssiCon_MSC_Und
GSE89179	4	siCon_MSC_ObvssiCon_MSC_Und
GSE89179	5	siCHD1_MSC_AdvssiCon_MSC_Ad
GSE89179	6	siCHD1_MSC_UndvssiCon_MSC_Und
GSE89179	7	siCHD1_MSC_ObvssiCon_MSC_Ob
22659600	1	OAvsNonOA
24361742	1	damagedvsundamaged
GSE72258	1	Rheumatoid.arthritis.synovial.fibroblast..HDAC1..25.nm.siRNA.knockdown..48.hvsRheumatoid.arthritis.synovial.fibroblast..NTC..25.nm.siRNA.knockdown..48.h
GSE72258	2	Rheumatoid.arthritis.synovial.fibroblast..C5orf30..50nm.siRNA..knockdown.24hvsRheumatoid.arthritis.synovial.fibroblast..NTC..50nm.siRNA..knockdown.24h
GSE69531	1	Plastic-PelletvsPlastic-Cell
GSE69531	2	ECM-PelletvsECM-Cell
GSE69531	3	ECM-PelletvsPlastic-Pellet
GSE69531	4	Plastic-PelletvsPlastic-Cell
GSE58203	1	IL1.1vsIL1.0
GSE58203	2	IL1.2vsIL1.0
GSE58203	3	IL1.4vsIL1.0
GSE58203	4	IL1.12vsIL1.0
GSE58203	5	PDGF.1vsPDGF.0
GSE58203	6	PDGF.2vsPDGF.0
GSE58203	7	PDGF.4vsPDGF.0
GSE58203	8	PDGF.12vsPDGF.0
GSE59642	1	osteoarthiritisvsreference
GSE59642	2	degenerated cartilagevsreference
GSE59642	3	degenerated cartilagevsosteoarthiritis
GSE64922	1	PlGF siRNAvscontrol siRNA
GSE60162	1	TBX5 overexpressionvsvector control
GSE31685	1	Interleukin.1beta.pre.stimulated.and.resveratrol.treatedvsNK..Interleukin.1beta.pre.stimulated
E-MEXP-3890	1	CD14-positive macrophagevsCD14-positive monocyte
GSE31980	1	MSC.aggregates.cultured.in.hanging.drop.culture.for.3.daysvsMSCs.in.a.monolayer.culture
GSE15615	1	TNFalphavsno cytokine
GSE15083	1	persistentvsextended
GSE108035	1	chondrocyte-like cells (ChiPS)vshuman induced pluripotent stem cells (GPCCi001-A)
GSE108035	2	chondrocyte-like cells (ChiPS)vschondrocyte cell line:  HC-402-05a
GSE108035	3	chondrocyte-like cells (ChiPS)vsprimary articular cartilage chondrocyte cell culture
GSE21959	1	HSF (healthy synovial fibroblasts) gene expression under hypoxic conditionsvsHSF (healthy synovial fibroblasts) gene expression under normoxic conditions
GSE21959	2	RASF (rheumatoid arthritis synovial fibroblasts) gene expression under hypoxic conditionsvsRASF (rheumatoid arthritis synovial fibroblasts) gene expression under normoxic conditions
GSE24742	1	EULAR Good-responder.12 weeks of RTX therapyvsEULAR Good-responder.baseline
GSE24742	2	EULAR Moderate-responder.12 weeks of RTX therapyvsEULAR Moderate-responder.baseline
GSE24742	3	EULAR Poor-responder.12 weeks of RTX therapyvsEULAR Poor-responder.baseline
GSE74668	1	treated with IL-17A _4hvsnon-treated control_4h
E-GEOD-57723	1	TNFvsnone
E-GEOD-57723	2	co-culture with fibroblastvsnone
E-GEOD-57723	3	TNF and co-culture with fibroblastvsnone
E-GEOD-83930	1	Pre-miR-17vsNC-Pre-miR
GSE100268	1	HPIP_KOvsControl
GSE10024	1	NDSF stimulated chondrocytesvsunstimulated chondrocytes
GSE10024	2	RASF stimulated chondrocytesvsunstimulated chondrocytes
E-GEOD-12860	1	RASF stimulated chondrocytesvsNDSF stimulated chondrocytes
E-GEOD-12860	2	Chondrocytes stimulated with prednisolone (solu-decortin) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	3	Chondrocytes stimulated with prioxicam treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	4	Chondrocytes stimulated with azathioprine (imurek) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	5	Chondrocytes stimulated with diclofenac treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	6	Chondrocytes stimulated with methylprednisolone (urbason) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	7	Chondrocytes stimulated with sodium aurothiomalate (tauredon) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-12860	8	Chondrocytes stimulated with chloroquine phosphate (resochin) treated RASFvsNDSF stimulated chondrocytes
E-GEOD-14359	1	conventional ostosarcoma tissuevsNon-neoplastic primary osteoblast cells with limited live span in vitro
E-GEOD-14359	2	metastatis tissuevsconventional ostosarcoma tissue
E-GEOD-1919	1	rheumatoid arthritis.disease modifying antirheumatic drugsvsrheumatoid arthritis.non-steroidal anti-inflammatory drugs
E-GEOD-1919	2	rheumatoid arthritis.steroids, disease modifying antirheumatic drugs and non-steroidal anti-inflammatory drugsvsrheumatoid arthritis.non-steroidal anti-inflammatory drugs
E-GEOD-1919	3	rheumatoid arthritis.steroids, disease modifying antirheumatic drugs and non-steroidal anti-inflammatory drugsvsrheumatoid arthritis.disease modifying antirheumatic drugs
E-GEOD-1919	4	rheumatoid arthritis.disease modifying antirheumatic drugsvsnormal.none
E-GEOD-1919	5	rheumatoid arthritis.steroids, disease modifying antirheumatic drugs and non-steroidal anti-inflammatory drugsvsnormal.none
E-GEOD-1919	6	rheumatoid arthritis.non-steroidal anti-inflammatory drugsvsnormal.none
E-GEOD-1919	7	osteoarthritis.non-steroidal anti-inflammatory drugsvsnormal.none
E-GEOD-1919	8	osteoarthritis.nonevsnormal.none
E-GEOD-1919	9	osteoarthritis.non-steroidal anti-inflammatory drugsvsosteoarthritis.none
E-GEOD-19664	1	Pooled_6_MSCs_d3vsPooled_5_MSCs_d0
E-GEOD-19664	2	Pooled_7_MSCs_d7vsPooled_5_MSCs_d0
E-GEOD-19664	3	Pooled_8_MSCs_d14vsPooled_5_MSCs_d0
E-GEOD-19664	4	Pooled_6_MSCs_d3vsPooled_5_MSCs_d0
E-GEOD-19664	5	Pooled_7_MSCs_d7vsPooled_6_MSCs_d3
E-GEOD-19664	6	Pooled_8_MSCs_d14vsPooled_7_MSCs_d7
E-GEOD-19664	7	Pooled_10_Chondros_d3vsPooled_9_Chondros_d0
E-GEOD-19664	8	Pooled_11_Chondros_d7vsPooled_10_Chondros_d3
E-GEOD-19664	9	Pooled_12_Chondros_d14vsPooled_11_Chondros_d7
E-GEOD-43923	1	osteophytic cartilagevsarticular cartilage
E-GEOD-51812	1	Chondrocyte_condensation_6wks_LCMvsArticular_chondrocytes_17wks
E-GEOD-51812	2	Remaining limb cells_6wks_LCMvsArticular_chondrocytes_17wks
E-GEOD-68760	1	X50.Âµg.ml.Galectin.1.for.24h.in.starvation.mediumvsuntreated
GSE82107	1	OsteoarthritisvsHealthy control
E-GEOD-9451	1	chondrocytevsiliac
E-GEOD-9451	2	osteoblastvsiliac
E-GEOD-9451	3	fibroblastvsiliac
E-GEOD-9451	4	adipocytevsiliac
E-MEXP-2019	1	intermediate cell derived from dendritic cellsvsdendritic cell
E-MEXP-2019	2	osteoclast derived from dendritic cellsvsintermediate cell derived from dendritic cells
E-MEXP-2019	3	intermediate cell derived from monocytesvsmonocyte
E-MEXP-2019	4	osteoclast derived from monocytesvsintermediate cell derived from monocytes
E-MEXP-2276	1	thanatophoric dysplasiavsnormal
E-MEXP-2488	1	articular cartilagevsnucleus pulposus
E-MEXP-3474	1	Kashin-beck diseasevsprimary osteoarthritis
E-MTAB-3010	1	DMEM-F12 + MIMIC miR450a-5pvsDMEM-F12
E-MTAB-3010	2	DMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 days + MIMIC miR28-5pvsDMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 days
E-MTAB-3010	3	DMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 daysvsDMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 2 days
E-MTAB-3010	4	DMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 21 daysvsDMEM + beta-glycerol phosphate, ascorbic acid and dexamethasone for 7 days
E-MTAB-4152	1	direct co-culture with human umbilical vein endothelial cellsvsindirect co-culture with human umbilical vein endothelial cells
E-MTAB-4152	2	indirect co-culture with human umbilical vein endothelial cellsvsmonoculture
E-MTAB-4152	3	direct co-culture with human umbilical vein endothelial cellsvsmonoculture
GSE100609	1	normal - osteoporosis: Osteoporosisvsnormal - osteoporosis: Normal
GSE100786	1	Bone marrow Monocytes from RA patientvsBone marrow Monocytes from OA patient
GSE100786	2	Peripheral blood Monocytes from RA patientvsPeripheral blood Monocytes from OA patient
GSE103697	1	ARP-1.5 ug/ml CRP for 24 hoursvsARP-1.Control
GSE103697	2	MM.1S.5 ug/ml CRP for 24 hoursvsMM.1S.Control
GSE103697	3	U266.5 ug/ml CRP for 24 hoursvsU266.Control
GSE104113	1	chondrocyte.Adultvschondrocyte.Juvenile
GSE104113	2	Stem cells.Adultvschondrocyte.Juvenile
GSE104113	3	chondrocyte.Adultvschondrocyte.Juvenile
GSE10575	1	migratory cells only found in diseased OA tissue with stem cell characteristicsvshealthy chondrocytes
GSE10575	2	Osteocytes/-blasts in P2 from human bone chips of patients with OAvshealthy chondrocytes
GSE10575	3	T/C-28 cells (fetal human sternal chondrocytes, immortalized, M.Goldring)vshealthy chondrocytes
GSE13604	1	mesenchymal stem cells treated 8 hours with BMP6vsmesenchymal stem cells cultured 8 hours without BMP6
GSE13837	1	TGF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	2	TGF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	3	TGF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	4	TGF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	5	TGF stimulated synovial fibroblasts (1h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	6	TGF stimulated synovial fibroblasts (2h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	7	TGF stimulated synovial fibroblasts (4h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	8	TGF stimulated synovial fibroblasts (12h).osteoarthritisvsTGF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	9	TGF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (1h).osteoarthritis
GSE13837	10	TGF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (2h).osteoarthritis
GSE13837	11	TGF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (4h).osteoarthritis
GSE13837	12	TGF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTGF stimulated synovial fibroblasts (12h).osteoarthritis
GSE13837	13	TNF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	14	TNF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	15	TNF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	16	TNF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (0h).rheumatoid arthritis
GSE13837	17	TNF stimulated synovial fibroblasts (1h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	18	TNF stimulated synovial fibroblasts (2h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	19	TNF stimulated synovial fibroblasts (4h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	20	TNF stimulated synovial fibroblasts (12h).osteoarthritisvsTNF stimulated synovial fibroblasts (0h).osteoarthritis
GSE13837	21	TNF stimulated synovial fibroblasts (1h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (1h).osteoarthritis
GSE13837	22	TNF stimulated synovial fibroblasts (2h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (2h).osteoarthritis
GSE13837	23	TNF stimulated synovial fibroblasts (4h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (4h).osteoarthritis
GSE13837	24	TNF stimulated synovial fibroblasts (12h).rheumatoid arthritisvsTNF stimulated synovial fibroblasts (12h).osteoarthritis
GSE16464	1	monolayer chondrocytes from OAvsmonolayer chondrocytes from normal
GSE16464	2	3D-cultured chondrocytes from OAvsmonolayer chondrocytes from OA
GSE19060	1	OAvsNormal
GSE27372	1	co-cultured with the JJN3 human myeloma cell linevscontrol
GSE27390	1	rheumatoid arthritisvsosteoarthritis
GSE29106	1	Measles Virus Nucleocapsid ProteinvsEmpty Vector
GSE29107	1	p62_wild_typevsp62_empty_vector
GSE29107	2	p62_P392Lvsp62_wild_type
GSE29745	1	Gene expression of human amnion infected 5 genesvsGene expression of human fetal re-differentiation chondrocytes
GSE29745	2	Gene expression of human adult re-differentiation chondrocytesvsGene expression of human fetal re-differentiation chondrocytes
GSE29745	3	Gene expression of human amnion infected 5 genesvsGene expression of human amnion
GSE35546	1	Kartogenin_1nM_6hvsDMSO
GSE35546	2	Kartogenin_10nM_6hvsDMSO
GSE35546	3	Kartogenin_100nM_6hvsDMSO
GSE35546	4	Kartogenin_1nM_24hvsDMSO
GSE35546	5	Kartogenin_10nM_24hvsDMSO
GSE35546	6	Kartogenin_100nM_24hvsDMSO
GSE35955	1	hMSC-old_elderlyvshMSC-C_middle-aged
GSE35956	1	diagnosis: primary osteoporosisvstissue: bone marrow
GSE35957	1	hMSC-senescentvshMSC-C_middle-aged
GSE35958	1	diagnosis: primary osteoporosisvstissue: bone marrow
GSE39340	1	ankylosing spondylitisvsrheumatoid arthritis
GSE39340	2	osteoarthritisvsrheumatoid arthritis
GSE39340	3	ankylosing spondylitisvsosteoarthritis
GSE39795	1	cartilage, middle zonevscartilage, deep zone
GSE39795	2	cartilage, superficial zonevscartilage, deep zone
GSE39795	3	cartilage, superficial zonevscartilage, middle zone
GSE41038	1	ankylosing spondylitisvsnormal control
GSE41038	2	seronegative spondyloarthropyvsnormal control
GSE41038	3	osteoarthritisvsnormal control
GSE41992	1	IL3vsnone
GSE42235	1	passage: 2vspassage: 0
GSE42235	2	passage: 4vspassage: 0
GSE42235	3	passage: 6vspassage: 0
GSE42235	4	passage: 8vspassage: 0
GSE45233	1	Knee meniscus, old, chondrosisvsKnee meniscus, young, chondrosis
GSE45233	2	Knee meniscus, old, chondrosisvsKnee meniscus, old, no chondrosis
GSE45233	3	Knee meniscus, young, chondrosisvsKnee meniscus, young, no chondrosis
GSE45233	4	Knee meniscus, old, no chondrosisvsKnee meniscus, young, no chondrosis
GSE46053	1	MSCs from healthy Donor cocultured with MM.1S cellsvsMSCs from healthy Donor cultured in solitary (i.e. no cocultured)
GSE46053	2	MSCs from MM patient cocultured with MM.1S cellsvsMSCs from healthy Donor cultured in solitary (i.e. no cocultured)
GSE46750	1	cultured.cells.from.synovial.membrane..inflammatoryvscultured.cells.from.synovial.membrane.normal.reactive
GSE51588	1	OA-Subchondral bone from medial tibialvsNormal-Subchondral bone from medial tibial
GSE51588	2	OA-Subchondral bone from lateral tibialvsNormal-Subchondral bone from lateral tibial
GSE51588	3	OA-Subchondral bone from medial tibialvsOA-Subchondral bone from lateral tibial
GSE52817	1	dOB (osteoblasts)vsgingival fibroblasts
GSE52817	2	dOB (osteoblasts)vsosteoblasts (OB)
GSE52817	3	dOB (osteoblasts)vsmesenchymal stem cells (MSC)
GSE52817	4	osteoblasts (OB)vsgingival fibroblasts
GSE55235	1	synovial tissue from rheumatoid arthritis jointvssynovial tissue from osteoarthritic joint
GSE55235	2	synovial tissue from rheumatoid arthritis jointvssynovial tissue from healthy joint
GSE55235	3	synovial tissue from osteoarthritic jointvssynovial tissue from healthy joint
GSE55457	1	rheumatoid arthritisvsosteoarthritis
GSE55457	2	rheumatoid arthritisvsnormal control
GSE55584	1	rheumatoid arthritisvsosteoarthritis
GSE57218	1	OAvsPreserved
GSE60762	1	OsteoarthriticvsHealthy
GSE62914	1	iPSC differentiated to chondrocyte for 4 daysvsiPSC
GSE62914	2	iPSC differentiated to chondrocyte for 9 daysvsiPSC
GSE62914	3	iPSC-derived chondrocytes (passage 3)vsiPSC
GSE62914	4	iPSC-derived chondrocytes (passage 3)vsadult chondrocyte
GSE64394	1	OA chondrocytesvsNormal chondrocytes
GSE66635	1	injured meniscusvsnormal articular cartilage
GSE68038	1	cartilage from knee (tibial plateau)vscartilage from proximal interphalangeal joint (PIP)
GSE68428	1	untreated + IL1vsuntreated
GSE68428	2	neg vehicle control + IL1vsuntreated
GSE68428	3	Lama4 + IL1vsuntreated
GSE69459	1	resFOP-iMSCs (+ActA)vsresFOP-iMSCs (-ActA)
GSE69459	2	FOP-iMSCs (+ActA)vsFOP-iMSCs (-ActA)
GSE69459	3	FOP-iMSCs (+ActA)vsresFOP-iMSCs (+ActA)
GSE69459	4	FOP-iMSCs (+ActA)vsresFOP-iMSCs (-ActA)
GSE69992	1	MSX1 siRNAvscontrol siRNA
GSE70719	1	fluoride (8 ppm) for 30 daysvsnone (untreated control)
GSE7116	1	Multiple Myeloma patient with osteonecrosis of the jawvsMultiple Myeloma patient on bisphosphonate therapy without osteonecrosis of the jaw
GSE7116	2	Multiple Myeloma patient with osteonecrosis of the jawvsHealthy volunteer
GSE7116	3	Multiple Myeloma patient on bisphosphonate therapy without osteonecrosis of the jawvsHealthy volunteer
GSE72575	1	IL-1Î²-stimulated in the presence of alloxanvsnon-stimulated
GSE72575	2	IL-1Î²-stimulated in the presence of GlcNvsnon-stimulated
GSE72575	3	IL-1Î²-stimulated in the presence of GlcN and alloxanvsnon-stimulated
GSE72575	4	IL-1Î²-stimulated MH7Avsnon-stimulated
GSE75181	1	cultured chondrocytes from cartilage_COTvscultured chondrocytes from cartilage_control
GSE75181	2	cultured chondrocytes from cartilage_ctrl_IL1Bvscultured chondrocytes from cartilage_control
GSE75181	3	cultured chondrocytes from cartilage_COT_IL1Bvscultured chondrocytes from cartilage_control
GSE75230	1	OIM treated, grow at 39oCvsuntreated, grow at 39oC in BM
GSE7669	1	fibroblasts_RAvsfibroblasts_OA
GSE77916	1	EPZ.5676.3.ÂµM.4.daysvsvehicle..DMSO..4.days
GSE85254	1	chondrocytes, Gal-3, 50 Âµg/mlvschondrocytes, untreated
GSE86578	1	IL.1.OSM.1vsnone (control).0
GSE86578	2	IL.1.OSM.1.25vsnone (control).0
GSE86578	3	IL.1.OSM.24vsnone (control).0
GSE9329	1	OsteoarthritisvsRhumatoid arthritis
GSE93698	1	diffuse systemic sclerosisvsMicrocrystalline arthritis
GSE93698	2	diffuse systemic sclerosisvsOsteoarthritis
GSE93698	3	diffuse systemic sclerosisvsRheumatoid arthritis
GSE93698	4	diffuse systemic sclerosisvsSeronegative arthritis
GSE93698	5	diffuse systemic sclerosisvsSystemic lupus erythematosus
GSE93698	6	Microcrystalline arthritisvsOsteoarthritis
GSE93698	7	Microcrystalline arthritisvsRheumatoid arthritis
GSE93698	8	Microcrystalline arthritisvsSeronegative arthritis
GSE93698	9	Microcrystalline arthritisvsSystemic lupus erythematosus
GSE93698	10	OsteoarthritisvsRheumatoid arthritis
GSE93698	11	OsteoarthritisvsSeronegative arthritis
GSE93698	12	OsteoarthritisvsSystemic lupus erythematosus
GSE93698	13	Rheumatoid arthritisvsSeronegative arthritis
GSE93698	14	Rheumatoid arthritisvsSystemic lupus erythematosus
GSE93698	15	Seronegative arthritisvsSystemic lupus erythematosus
E-GEOD-69110	1	SOX9vseGFP
E-MTAB-4304	1	DamagedvsIntact
E-MTAB-4879	1	osteocyte_oldvsosteocyte_young
E-MTAB-4879	2	chondrocyte_oldvschondrocyte_young
E-MTAB-4879	3	tendon_oldvstendon_young
E-MTAB-4879	4	msc_oldvsmsc_young
E-MTAB-5564	1	osteoarthritisvsnormal
E-MTAB-6266	1	OAvsnonOA
GSE77753	1	EDS-HT/JHSvshealthy
GSE43861	1	Fibrogenesis imperfecta ossiumvscontrol
GSE112809	1	PBMC after 56 days of CPN10 treatmentvsPBMC at baseline
GSE111946	1	synthetic precursor miR-218vsscrambled control
GSE111946	2	inhibitors of miR-218vsAnti-miR Negative Control
E-MTAB-3201	1	psoriatic arthritis.synovial fluidvshealthy.synovial fluid
E-MTAB-6700	1	Staphylococcus aureus strain SK2vsnone
GSE54749	1	treated.with.Hh.inhibitorvsnone
GSE74220	1	IL1BvsControl
GSE114007	1	OAvsNonOA
GSE109503	1	Day21vsDay14
GSE109503	2	Day14vsDay7
GSE109503	3	Day7vsDay3
GSE109503	4	Day3vsDay1
GSE109503	5	Day1vsDay0
GSE109503	6	Day21vsDay0
GSE109503	7	Day14vsDay0
GSE109503	8	Day7vsDay0
GSE109503	9	Day3vsDay0
GSE109503	10	Day1vsDay0
GSE109108	1	mir138_day2vsNS_control_day2
GSE109108	2	mir138_day7vsNS_control_day7
GSE109108	3	mir181_day2vsNS_control_day2
GSE109108	4	mir181_day7vsNS_control_day7
GSE57218_B	1	OAvsHealthy
GSE57218_B	2	PreservedvsHealthy
GSE99662	1	HighvsLow
GSE73087	1	MSC-Day1 Induction-ApoA1vsMSC-Day1-Induction
GSE73087	2	MSC-Day3-Induction-ApoA1vsMSC-Day3-Induction
GSE73087	3	MSC-Day5-Induction-ApoA-1vsMSC-Day5-Induction
GSE121892	1	transfected.with.miR.320a.inhibitor..I.vstransfected.with.control.inhibitor..CI.
GSE121892	2	transfected.with.miR.320a.mimic..M.vstransfected.with.control.mimic..CM.
GSE114237	1	MG-63, mineralized bonevsMG-63, demineralized bone
GSE108771	1	Activinvscontrol
GSE108771	2	Activin + CP-724714vscontrol
GSE108771	3	Activin + Lapatinibvscontrol
GSE108771	4	Activin + TAKvscontrol
GSE113253	1	BM-hMSC-TERT4 osteoblast diff 7dvsBM-hMSC-TERT4 undifferentiated
GSE113253	2	BM-hMSC-TERT4 osteoblast diff 3dvsBM-hMSC-TERT4 undifferentiated
GSE113253	3	BM-hMSC-TERT4 osteoblast diff 1dvsBM-hMSC-TERT4 undifferentiated
GSE113253	4	BM-hMSC-TERT4 osteoblast diff 4hvsBM-hMSC-TERT4 undifferentiated
GSE125167	1	Control_10_days_difvsControl_2_days_dif
GSE125167	2	Control_2_days_difvsNaiveControl
GSE125167	3	PLZF_10_days_diffvsPLZF_2_days_diff
GSE125167	4	PLZF_2_days_diffvsNaivePLZF
GSE125167	5	PLZF_10_days_diffvsControl_10_days_dif
GSE125167	6	PLZF_2_days_diffvsControl_2_days_dif
GSE125167	7	NaivePLZFvsNaiveControl
GSE28074	1	mesenchymal stem cells treated 8 hours with BMP6, and harvested at 8 hoursvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	2	mesenchymal stem cells treated 8 hours with BMP6, and harvested at 24 hoursvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	3	mesenchymal stem cells treated 8 hours with BMP6, and harvested at 96 hoursvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	4	mesenchymal stem cells treated 8 hours with BMP6, and harvested at 10 daysvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	5	mesenchymal stem cells treated 24 hours with BMP6, and harvested at 24 hoursvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	6	mesenchymal stem cells treated 24 hours with BMP6, and harvested at 96 hoursvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	7	mesenchymal stem cells treated 24 hours with BMP6, and harvested at 10 daysvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	8	mesenchymal stem cells treated 96 hours with BMP6, and harvested at 96 hoursvsmesenchymal stem cells cultured 8 hours without BMP6
GSE28074	9	mesenchymal stem cells treated 96 hours with BMP6, and harvested at 10 daysvsmesenchymal stem cells cultured 8 hours without BMP6
GSE80285	1	treated with 40ng/ml recombinant a-Klotho for 7 daysvsuntreated
GSE80285	2	transfected with siRNA against a-Klothovstransfected with siRNA control
GSE150411	1	FNF, 3 hoursvsPBS, 3 hours
GSE150411	2	FNF, 6 hoursvsPBS, 6 hours
GSE150411	3	FNF, 18 hoursvsPBS, 18 hours
GSE151937	1	ATX_inhibitorvsDMSO
GSE152782	1	OA_C9vsOA_Mock
GSE152782	2	OA_CHIKVvsOA_Mock
GSE128532	1	IFT88_0hrvscontrol_0hr
GSE128532	2	IFT88_1hrvscontrol_1hr
GSE128532	3	IFT88_2hrvscontrol_2hr
GSE128532	4	IFT88_4hrvscontrol_4hr
GSE128532	5	IFT88_8hrvscontrol_8hr
GSE128532	6	IFT88_24hrvscontrol_24hr
GSE143514	1	OAvscontrol
GSE117084	1	ESC_CBX4_KOvsESC_CBX4_WT
GSE117084	2	MSC_CBX4_KOvsMSC_CBX4_WT
GSE110268_1	1	FOXD1 Knockdownvsnon-targeting control
GSE110268_2	1	YAP KO_ESCvsWT_ESC
GSE110268_2	2	TAZ KO_ESCvsWT_ESC
GSE110268_2	3	TAZ KO_MSCvsWT_MSC
GSE110268_2	4	YAP KO_MSCvsWT_ESC
GSE112318_2	1	hBMSC_2_weekvshBMSC_0_week
GSE141610	1	DenosumabvsPlacebo
GSE15602	1	RA Synovial biopsy T12 post-adalimumab therapy, ModeratevsRA Synovial biopsy T12 post-adalimumab therapy, Poor
GSE15602	2	RA Synovial biopsy T12 post-adalimumab therapy, GoodvsRA Synovial biopsy T12 post-adalimumab therapy, Poor
GSE15602	3	RA Synovial biopsy T12 post-adalimumab therapy, GoodvsRA Synovial biopsy T12 post-adalimumab therapy, Moderate
GSE148728	1	COL10A1 G18E mutantvsCOL10A1 G18E isogenic control
GSE148728	2	COL10A1 S600P mutantvsCOL10A1 S600P and MATN3 R209P isogenic control
GSE148728	3	COL10A1 L614RfsX8 mutantvsCOL10A1 L614RfsX8 isogenic control
GSE148728	4	MATN3 T120M mutantvsMATN3 T120M isogenic control
GSE148728	5	MATN3 R209P mutantvsCOL10A1 S600P and MATN3 R209P isogenic control
GSE129147	1	damagevshealthy
GSE156508	1	OsteoarthritisvsFracture
GSE157322	1	PolynesianvsEuropean
GSE144367	1	miR-140-3p.2vsmiControl
GSE144367	2	miR-140-3p.1vsmiControl
GSE156565	1	HIF1A siRNAvscontrol siRNA
GSE156565	2	EPAS1 siRNAvscontrol siRNA
GSE143725	1	DeletionvsControl
GSE142831	1	Adipo tissue_CartilagevsAdipose tissue
E-MTAB-10476	1	t15mvst0h
E-MTAB-10476	2	t30mvst0h
E-MTAB-10476	3	t1hvst0h
E-MTAB-10476	4	t2hvst0h
E-MTAB-10476	5	t4hvst0h
E-MTAB-10476	6	t8hvst0h
E-MTAB-10476	7	t16hvst0h
E-MTAB-10476	8	t121dvst0h
E-MTAB-10476	9	Monovst0h
GSE109419	1	ACLandMeniscusTearvsACLTear
GSE110606	1	osteoarthritisvshealthy
GSE111358	1	OAvsNOF
GSE131822	1	Galectin-8vscontrol
GSE142823	1	BDNFvscontrol
GSE142823	2	NGFvscontrol
GSE145019_2	1	CLOCK defecient hMSCsvsWT hMSCs
GSE145048	1	human_joint_progenitor-like_cellsvshuman_embryonic_chondroprogenitors
GSE152080	1	iPSC_MC_ChvsChondrocyte
GSE152080	2	iPSC_NCC_ChvsiPSC_MC_Ch
GSE152638	1	hsa-miR-27b-3p_mimicvscontrol
GSE157955	1	day 56 of inductionvsday -1 of induction
GSE157955	2	day 28 of inductionvsday -1 of induction
GSE158071	1	Irradiation 3Gy 1hvsControl 1h
GSE158071	2	Irradiation 2Gy 1hvsControl 1h
GSE158071	3	Irradiation 1Gy 1hvsControl 1h
GSE158071	4	Irradiation 3Gy 24hvsControl 24h
GSE158071	5	Irradiation 2Gy 24hvsControl 24h
GSE158071	6	Irradiation 1Gy 24hvsControl 24h
GSE158875	1	IL1B_TNF_4hrsvsPBS
GSE162510	1	Ze14_10percentvscontrol
GSE162510	2	Ze14_20percentvscontrol
GSE162510	3	IL_1vscontrol
GSE162510	4	IL_1_Ze14_10percentvscontrol
GSE162510	5	IL_1_Ze14_20percentvscontrol
GSE162691	1	IL-1Beta_ADvsControl_AD
GSE162691	2	IL-1Beta_FTvsControl_FT
GSE162691	3	IL-1Beta_OC-OvsControl_OC-O
GSE162691	4	IL-1Beta_OC-CvsControl_OC-C
GSE165874	1	StrainvsControl
GSE165930	1	AcetabulumvsIlium
GSE165930	2	IschiumvsIlium
GSE165930	3	PubisvsIlium
GSE166535	1	cartilage_from_OA_patientvsNo_substrate
GSE166535	2	dentinevsNo_substrate
GSE167852	1	semaphorin_4Dvscontrol
GSE169077	1	LATE STAGE OA CARTILAGEvsNORMAL CARTILAGE
GSE171952	1	Cartilage_IL_17AFvsCartilage_Control
GSE171952	2	Cartilage_IL_17AvsCartilage_Control
GSE171952	3	Cartilage_IL_17FvsCartilage_Control
GSE171952	4	Synovium_IL_17AFvsSynovium_Control
GSE171952	5	Synovium_IL_17AvsSynovium_Control
GSE171952	6	Synovium_IL_17FvsSynovium_Control
GSE172291	1	SR3335vsDMSO
GSE176199	1	senescent_mesenchymal_stromal_cellsvsmesenchymal_stromal_cells
GSE183954	1	Ad_KLF4_transduced_without_IL_1b_stimulationvsAd_EGFP_transduced_without_IL_1b_stimulation
GSE183954	2	Ad_KLF4_transduced_with_IL_1b_stimulationvsAd_KLF4_transduced_without_IL_1b_stimulation
GSE183954	3	Ad_EGFP_transduced_with_IL_1b_stimulationvsAd_EGFP_transduced_without_IL_1b_stimulation
GSE184007	1	Week_15vsWeek_8
GSE184007	2	Week_11vsWeek_8
GSE184062	1	CA2_shRNAvsScrambled
GSE188353	1	STAT3_shRNA_lentiviral_particlesvsscrambled_lentiviral_particles
GSE188759	1	ChondrogenesisvsControl
GSE191136	1	Day28vsDay3
GSE191136	2	Day16vsDay3
GSE191136	3	Day9vsDay3
GSE191136	4	Day6vsDay3
GSE192982	1	SMG_FvsStatic_F
GSE192982	2	CHP_FvsStatic_F
GSE192982	3	SMG_MvsStatic_M
GSE192982	4	CHP_MvsStatic_M
GSE197921	1	SDF1a_SKHSvsDMSO
GSE197921	2	SDF1a_AstragalosidevsDMSO
GSE197921	3	SDF1avsDMSO
GSE199847	1	Hypertrophic_mediumvsGrowth_medium
GSE205196	1	high_frequency_strainvsstatic_control
GSE205196	2	low_frequency_strainvsstatic_control
GSE206213	1	WRN_KD_Day_4vsWT_Day_4
GSE206213	2	WRN_KD_Day_9vsWT_Day_9
GSE207881	1	osteoarthritic.human.cartilagevshealthy.human.cartilage
GSE208277	1	RORB_OEvsWT
GSE210984	1	Day7_DiffvsMesenchymal stem cells MSC
GSE210984	2	Day14_DiffvsMesenchymal stem cells MSC
GSE210984	3	Day21_DiffvsMesenchymal stem cells MSC
GSE213070	1	InflamedvsControl
GSE47726	1	RespondervsNONResponder
GSE81526	1	AdultvsFetal
GSE81526	2	Adult_DrugvsAdult_Control
GSE12860	1	RASF stimulated chondrocytesvsNDSF stimulated chondrocytes
GSE12860	2	Chondrocytes stimulated with prednisolone (solu-decortin) treated RASFvsNDSF stimulated chondrocytes
GSE12860	3	Chondrocytes stimulated with prioxicam treated RASFvsNDSF stimulated chondrocytes
GSE12860	4	Chondrocytes stimulated with azathioprine (imurek) treated RASFvsNDSF stimulated chondrocytes
GSE12860	5	Chondrocytes stimulated with diclofenac treated RASFvsNDSF stimulated chondrocytes
GSE12860	6	Chondrocytes stimulated with methylprednisolone (urbason) treated RASFvsNDSF stimulated chondrocytes
GSE12860	7	Chondrocytes stimulated with sodium aurothiomalate (tauredon) treated RASFvsNDSF stimulated chondrocytes
GSE12860	8	Chondrocytes stimulated with chloroquine phosphate (resochin) treated RASFvsNDSF stimulated chondrocytes
GSE160886	1	Chondrogenic progenitor cell culturevsMesenchymal stem cell culture
GSE183531	1	Gal4vsCtrl
GSE185440	1	transfected with Gapmer Hotairvstransfected with Gapmer control
GSE186689	1	IL1vsCon
GSE186689	2	IL1_TSAvsCon
GSE186689	3	Con_TSAvsCon
GSE198049	1	CD200pos sorted cellsvsCD200neg sorted cells
GSE206848	1	Late stage OA - synovium procured during knee replacement surgeryvsNormal synovium procured at autopsy
GSE210826	1	48hr HU308vsuntreated
GSE210826	2	4hr HU308vsuntreated
GSE213277	1	CTR9 KnockdownvsControl Knockdown
GSE216832	1	HOvsWT
GSE70667	1	Flow_2hvsControl_2h
GSE87608	1	Runx2HET_vehiclevsWT_vehicle
GSE87608	2	WT_MS275vsWT_vehicle
GSE87608	3	Runx2HET_MS275vsRunx2HET_vehicle
GSE87608	4	Runx2HET_MS275vsWT_MS275
GSE90890	1	Cdc73fKOvsWT
GSE97118	1	WT_D7vsWT_D3
GSE97118	2	WT_D14vsWT_D7
GSE97118	3	Ezh2_cKO_D7vsEzh2_cKO_D3
GSE97118	4	Ezh2_cKO_D14vsEzh2_cKO_D7
GSE97118	5	Ezh2_cKO_D7vsWT_D7
GSE97118	6	Ezh2_cKO_D14vsWT_D14
GSE97118	7	Ezh2_cKO_D3vsWT_D3
GSE57740	1	shRNA specific for CHADLvsscrambled negative control shRNA
GSE52992	1	human TNF transgenic and knockout in Rsk2 gene (Rsk2-/y FLS)vshuman TNF transgenic without knockout (Rsk2+/y FLS)
GSE17160	1	Wild-type.LPS-treatedvsWild-type.none
GSE17160	2	Wild-type.HA-treatedvsWild-type.none
GSE17160	3	Wild-type.TSG6-treatedvsWild-type.none
GSE17160	4	Wild-type.TNFa-treatedvsWild-type.none
GSE17160	5	TSG-6 knockout.LPS-treatedvsTSG-6 knockout.none
GSE17160	6	TSG-6 knockout.HA-treatedvsTSG-6 knockout.none
GSE17160	7	TSG-6 knockout.TSG6-treatedvsTSG-6 knockout.none
GSE17160	8	TSG-6 knockout.TNFa-treatedvsTSG-6 knockout.none
GSE17160	9	TSG-6 knockout.LPS-treatedvsWild-type.LPS-treated
GSE17160	10	TSG-6 knockout.HA-treatedvsWild-type.HA-treated
GSE17160	11	TSG-6 knockout.TSG6-treatedvsWild-type.TSG6-treated
GSE17160	12	TSG-6 knockout.TNFa-treatedvsWild-type.TNFa-treated
GSE22971	1	MMP-8 KO control mousevsMMP-8 wild type control mouse
GSE22971	2	MMP-8 KO arthritic mousevsMMP-8 wild type arthritic mouse
GSE22971	3	MMP-8 wild type arthritic mousevsMMP-8 wild type control mouse
GSE22971	4	MMP-8 KO arthritic mousevsMMP-8 KO control mouse
GSE13590	1	siRNA-140vssiRNA-96
GSE13590	2	antimicroRNA-140vsantimicroRNA-449
GSE99731	1	DMM.1 wkvssham.1 wk
GSE99731	2	DMM.6 wkvssham.6 wk
GSE99731	3	DMM.6 wkvsDMM.1 wk
GSE27492	1	Ankle.D01vsAnkle.D00
GSE27492	2	Ankle.D03vsAnkle.D00
GSE27492	3	Ankle.D07vsAnkle.D00
GSE27492	4	Ankle.D12vsAnkle.D00
GSE27492	5	Ankle.D18vsAnkle.D00
GSE27492	6	Synovial fluid.D07vsSynovial fluid.D03
GSE27492	7	Synovial fluid.D12vsSynovial fluid.D03
GSE27492	8	Synovial fluid.D18vsSynovial fluid.D03
GSE107592	1	Adult CartilagevsEmbryonic Cartilage
GSE92641	1	Uhrf1KOvsControl
GSE107849	1	RORB_KOvsControl
GSE15118	1	The CH10T1/2 cell line transfected with the wild type PTHR1 treated with PTHrPvsThe CH10T1/2 cell line transfected with the wild type PTHR1
GSE15118	2	The CH10T1/2 cell line transfected with the R150C variant PTHR1 treated for one hour with PTHrPvsThe CH10T1/2 cell line transfected with the R150C variant PTHR1 treated with carrier
GSE15118	3	The CH10T1/2 cell line transfected with the R150C variant PTHR1 treated for one hour with PTHrPvsThe CH10T1/2 cell line transfected with the wild type PTHR1 treated with PTHrP
GSE15118	4	The CH10T1/2 cell line transfected with the R150C variant PTHR1 treated with carriervsThe CH10T1/2 cell line transfected with the wild type PTHR1
E-GEOD-16007	1	microRNA-140 depletionvscontrol
E-GEOD-17473	1	tissue: TMJ condyle; developmental stage: embryo; age: E16.5vstissue: TMJ fossa; developmental stage: embryo; age: E16.5
E-GEOD-18647	1	Cre.;Tgfbr2lox/wt.Intervertebral disc (IVD)vsCre.;Tgfbr2lox/lox.Intervertebral disc (IVD)
E-GEOD-18647	2	Cre.;Tgfbr2lox/wt.VertebraevsCre.;Tgrbr2lox.lox.Vertebrae
E-GEOD-18647	3	Cre.;Tgfbr2lox/wt.Intervertebral disc (IVD)vsCre.;Tgfbr2lox/wt.Vertebrae
E-GEOD-18647	4	Cre.;Tgfbr2lox/lox.Intervertebral disc (IVD)vsCre.;Tgrbr2lox.lox.Vertebrae
E-GEOD-18648	1	TGF.beta1vsnone
E-GEOD-18648	2	BMP4vsnone
E-GEOD-2154	1	X15vsX12
E-GEOD-2154	2	X12vsX9
E-GEOD-2154	3	X9vsX6
E-GEOD-2154	4	X6vsX3
E-GEOD-26475	1	Murine knee joint_Operated (DMM)_6hrvsMurine knee joint_Operated (Sham)_6hr
E-GEOD-26475	2	Murine knee joint_Operated (DMM)_3dayvsMurine knee joint_Operated (Sham)_3day
E-GEOD-26475	3	Murine knee joint_Operated (DMM)_7daysvsMurine knee joint_Operated (Sham)_7days
E-GEOD-33567	1	Mouse C2C12 cells (96h)vsMouse C2C12 cells (0h)
E-GEOD-33567	2	Mouse C2C12 cells treated with BMP2 (96h)vsMouse C2C12 cells (96h)
GSE37287	1	Interdigital Tissue Tbr2Prx1KO mutantsvsInterdigital Tissue Controls
GSE37287	2	Growth Plate Chondrocyte Tgfbr2Prx1KO  mutantsvsGrowth Plate Chondrocyte Controls
GSE37287	3	Interzone Tgfbr2Prx1KO mutantsvsInterzone Controls
GSE51994	1	SZvsMZ
GSE51994	2	SZvsDZ
GSE51994	3	MZvsDZ
E-GEOD-54216	1	superficial zonevsintermediate/deep zone
E-GEOD-54216	2	superficial zonevsresting zone
E-GEOD-54216	3	intermediate/deep zonevsresting zone
E-GEOD-6119	1	IL-1vscontrol
E-GEOD-6119	2	glucosaminevscontrol
E-GEOD-6119	3	IL-1 and glucosaminevscontrol
GSE65077	1	Over expression day 1vsControl day 1
E-GEOD-8077	1	contralateral osteoarthritis inductionvsipsilateral osteoarthritic induction
E-GEOD-8077	2	contralateral osteoarthritis inductionvssham surgery
E-GEOD-8077	3	ipsilateral osteoarthritic inductionvssham surgery
E-MEXP-1244	1	dexamethasonevsnone
E-MTAB-1123	1	wild type.12vswild type.6
E-MTAB-1123	2	mOL-AR knockout.12vsmOL-AR knockout.6
E-MTAB-1123	3	mOL-AR knockout.12vswild type.12
E-MTAB-1123	4	mOL-AR knockout.6vswild type.6
E-MTAB-1391	1	X27vsX9
E-MTAB-1391	2	X27vsX0
E-MTAB-1391	3	X9vsX0
E-MTAB-2450	1	control.rhBMP2vscontrol.none
E-MTAB-2450	2	miR-195 transfection.rhBMP2vsmiR-195 transfection.none
E-MTAB-2450	3	miR-195 transfection.rhBMP2vscontrol.rhBMP2
E-MTAB-2450	4	miR-195 transfection.nonevscontrol.none
E-MTAB-5023	1	Mesenchymal cell-specific homozygous deletion of SbdsvsSbds wildtype
E-MTAB-5326	1	25 MPa pressure.1vsno hydrostatic pressure.NA
E-MTAB-5326	2	25 MPa pressure.4vsno hydrostatic pressure.NA
E-MTAB-5326	3	25 MPa pressure.24vsno hydrostatic pressure.NA
GSE102588	1	X13del.tg.mutant.with.bone.overgrowthvswild.type
GSE103416	1	monosodium iodoacetate (MIA).2vsnaive.0
GSE103416	2	monosodium iodoacetate (MIA).14vsnaive.0
GSE103416	3	monosodium iodoacetate (MIA).28vsnaive.0
GSE104793	1	IL-1b treatedvsUntreated
GSE104794	1	Ad-Epas1(HIF-2a) infectedvsAd-null infected
GSE104795	1	Ad-Zip8 infectedvsAd-null infected
GSE105139	1	AhsgHETvsAhsgWT
GSE105139	2	AhsgKOvsAhsgWT
GSE105139	3	AhsgKOvsAhsgHET
GSE10555	1	osteoblast Slc39a13 knockoutvsosteoblast wild type
GSE10556	1	chondrocyte Slc39a13 knockoutvschondrocyte wild type
GSE106631	1	galectin-8 treated (50nM, 24hrs)vsnone
GSE13104	1	c2984, osteosarcoma from p53+/- mouse. Non-treated.vsCell type: mc3T3 mouse osteoblast, non-tumorigenic. Non-treated.
GSE13104	2	Osteosarcoma arisen from p53+/- mouse. Non-treated.vsCell type: mc3T3 mouse osteoblast, non-tumorigenic. Non-treated.
GSE13104	3	Rhabdomyosarcoma arisen from p53+/- mouse. Non-treated.vsCell type: mc3T3 mouse osteoblast, non-tumorigenic. Non-treated.
GSE16749	1	RAW 264.7, RANKL + M-CSFvsRAW 264.7, Unstimulated
GSE16749	2	RAW 264.7, Unstimulated, miR-155vsRAW 264.7, Unstimulated
GSE16749	3	RAW 264.7, RANKL + M-CSF, miR-155vsRAW 264.7, Unstimulated, miR-155
GSE17348	1	conditioned medium of MDA-PCa2b cellsvsconditioned medium of PC-3 cells
GSE17563	1	Differentiating precursorvsPrecursor
GSE17563	2	OsteoclastvsDifferentiating precursor
GSE17569	1	ALCAM(+) Sca-1(-)vsALCAM(-) Sca-1(-)
GSE17569	2	ALCAM(-) Sca-1(+)vsALCAM(-) Sca-1(-)
GSE17570	1	PDGFRa(+) Sca-1(+)vsPDGFRa(-) Sca-1(-)
GSE17570	2	PDGFRa(+) Sca-1(-)vsPDGFRa(-) Sca-1(-)
GSE18991	1	Hoxd4 transgenicvswild type
GSE18992	1	Hoxc8 transgenicvswild type
GSE19299	1	Rb KnockoutvsWild type
GSE19950	1	prothrombin adherent cells from long bonevsosteopontin adherent cells from long bone
GSE20850	1	osteoclasts cultured in the presence of M-CSF plus RANKL for six daysvsmacrophages cultured in the presence of M-CSF for six days
GSE21093	1	RCCSvscontrol
GSE21523	1	TERC-/-vsTERC+/+
GSE21639	1	RAW_RL_day1vsRAW_CTRL_day1
GSE21639	2	RAW_RL_day2vsRAW_CTRL_day2
GSE21639	3	RAW_RL_day4vsRAW_CTRL_day4
GSE21639	4	RAW_RL_day5vsRAW_CTRL_day5
GSE21710	1	time: 24 hvstime: 0 h
GSE21710	2	time: 12 hvstime: 0 h
GSE21710	3	time: 6 hvstime: 0 h
GSE22925	1	Wild type mice, endothelial, G-CSFvsWild type mice, endothelial, untreated
GSE22925	2	Wild type mice, osteoblasts, G-CSFvsWild type mice, osteoblasts, untreated
GSE26499	1	RANKlowFmshighvsRANKhighFmslow
GSE30160	1	knockin mutantvswild type
GSE30322	1	subchondral bone,operation,1 week postsurgeryvssubchondral bone,sham operation,1 week postsurgery
GSE30322	2	subchondral bone,operation,2 weeks postsurgeryvssubchondral bone,sham operation,2 weeks postsurgery
GSE30322	3	subchondral bone,operation,4 weeks postsurgeryvssubchondral bone,sham operation,4 weeks postsurgery
GSE30628	1	Col10a1 p.Asn617Lysvswild type
GSE30628	2	ColXTgcogvswild type
GSE32163	1	del175k mutantvswild-type
GSE33656	1	Frzb -/-vswild-type
GSE33754	1	age: 8 weeks.strain: Str/ortvsage: 8 weeks.strain: CBA
GSE33754	2	age: 18 weeks.strain: Str/ortvsage: 18 weeks.strain: CBA
GSE33754	3	age: 40 weeks.strain: Str/ortvsage: 40 weeks.strain: CBA
GSE34570	1	osteoblasts_2uM PP1_24hrvsosteoblasts_DMSO_24hr
GSE35003	1	Ift88-deletedvswild-type
GSE35466	1	bone marrow cells, adiponectin, 4 hrsvsbone marrow cells, unterated, 4 hrs
GSE35466	2	bone marrow cells, adiponectin, 10 hrsvsbone marrow cells, unterated, 10 hrs
GSE35466	3	bone marrow cells, adiponectin, 24 hrsvsbone marrow cells, unterated, 24 hrs
GSE35466	4	bone marrow cells, adiponectin, 72 hrsvsbone marrow cells, unterated, 72 hrs
GSE35466	5	bone marrow cells, adiponectin, 120 hrsvsbone marrow cells, unterated, 120 hrs
GSE36925	1	BMP2(-),LOXL2(+)vsBMP2(-),LOXL2(-)
GSE36925	2	BMP2(+),LOXL2(-)vsBMP2(-),LOXL2(-)
GSE36925	3	BMP2(+),LOXL2(+)vsBMP2(-),LOXL2(-)
GSE37219	1	NFATc1 fl/fl MxCre+vsNFATc1 fl/fl MxCre-
GSE37676	1	Mc3T3 cells_treated with AA_5 daysvsMc3T3_untreated_5 days
GSE41342	1	Gene expression data from DMM joints 2 weeks after surgeryvsGene expression data from sham controls 2 weeks after surgery
GSE41342	2	Gene expression data from DMM joints 4 weeks after surgeryvsGene expression data from sham controls 4 weeks after surgery
GSE41342	3	Gene expression data from DMM joints 8 weeks after surgeryvsGene expression data from sham controls 8 weeks after surgery
GSE41342	4	Gene expression data from DMM joints 16 weeks after surgeryvsGene expression data from sham controls 16 weeks after surgery
GSE41997	1	Estrogen Receptor alpha knock-outvscontrol
GSE42295	1	surgery: OA.time after surgery: 2 weeksvssurgery: Sham.time after surgery: 2 weeks
GSE42295	2	surgery: OA.time after surgery: 8 weeksvssurgery: Sham.time after surgery: 8 weeks
GSE42295	3	surgery: OA.time after surgery: 8 weeksvssurgery: OA.time after surgery: 2 weeks
GSE43242	1	Osteoblast specific beta-catenin constitutively expressedvswild type
GSE43242	2	Osteoblast specific FoxO1 deletedvswild type
GSE43663	1	PG4P1vsWTP1
GSE43854	1	mutant (Gnptabc.3082insC)vswild-type
GSE45656	1	pre-osteoclastsvsMouse bone marrow macrophage
GSE45656	2	mature osteoclasts on platevspre-osteoclasts
GSE45656	3	mature resorbing osteoclasts on dentinvspre-osteoclasts
GSE45793	1	Adamts5Dcat DMM 6wkvsAdamts5Dcat Sham 6wk
GSE45793	2	Adamts5Dcat DMM 1wkvsAdamts5Dcat Sham 1wk
GSE45793	3	WT DMM 6wkvsWT Sham 6wk
GSE45793	4	WT DMM 2wkvsWT Sham 2wk
GSE45793	5	WT DMM 1wkvsWT Sham 1wk
GSE46390	1	CSF1vscontrol
GSE48438	1	Scl-tTA::TRE-BCR/ABLvsControl
GSE50549	1	SAHA2hrvsDMSO
GSE50549	2	SAHA6hrvsDMSO
GSE51098	1	Intermediate interzonevsouter interzone
GSE53857	1	X2.wks.post.surgery_treatedvsX2.wks.post.surgery_untreated
GSE53857	2	X4.wks.post.surgery_treatedvsX4.wks.post.surgery_untreated
GSE53857	3	X8.wks.post.surgery_treatedvsX8.wks.post.surgery_untreated
GSE53982	1	differentiating MC3T3-E1 cells treated with control scramble shRNAvsproliferating MC3T3-E1 cells treated with control scramble shRNA
GSE53982	2	differentiating MC3T3-E1 cells treated with Runx2-specific shRNAvsdifferentiating MC3T3-E1 cells treated with control scramble shRNA
GSE54779	1	Bone marrow monocytes treated with M-CSF and sRANKLvsBone marrow monocytes treated with M-CSF alone
GSE55900	1	Lrp5KOvsLrp5WT
GSE57104	1	Rs1 expressing osteoblastsvswild type osteoblasts
GSE59387	1	Dnmt3a knockoutvswild type
GSE60401	1	SXR_EtvsDsRed_Et
GSE60401	2	SXR_VK2vsDsRed_VK2
GSE60651	1	overexpressing A-CEBPvsoverexpressing GFP
GSE60737	1	overexpressing HES1vsoverexpressing GFP
GSE60761	1	genotype: wildtype.treatment: Calcitoninvsgenotype: wildtype.treatment: untreated
GSE60761	2	genotype: CalcrKO.treatment: Calcitoninvsgenotype: CalcrKO.treatment: untreated
GSE60761	3	genotype: CalcrKO.treatment: Calcitoninvsgenotype: wildtype.treatment: Calcitonin
GSE60761	4	genotype: CalcrKO.treatment: untreatedvsgenotype: wildtype.treatment: untreated
GSE63017	1	Pax1KOvsWT
GSE63017	2	Pax1HETvsWT
GSE63017	3	Pax1KOPax9KOvsWT
GSE63017	4	Pax1KOPax9HETvsWT
GSE63939	1	Osteoblastic in vitro differentiation of Kusa4b10 mouse cell line.vsKusa4b10 mouse cell line
GSE63939	2	Osteoblastic in vitro differentiation of Kusa4b10 mouse cell line.vsOsteosarcoma cell line
GSE64141	1	after 15 days of differentiation in chondrogenic mediavsprior to differentiation
GSE64965	1	X482.cells.Sox2shRNA.vsX482.cells.scrambledshRNA
GSE65745	1	X500.ng.ml.doxycyclinevsvehicle..control.
GSE65745	2	X10nM.E2vsvehicle..control.
GSE65745	3	X500.ng.ml.doxycycline.and.10nM.E2vsvehicle..control.
GSE66416	1	MC3T3-E1_over-expressing_periostinvsMC3T3-E1_empty_vector
GSE66554	1	newbornvsadult
GSE66554	2	youthvsadult
GSE66554	3	early-stage elderlyvsadult
GSE66554	4	latter-stage elderlyvsadult
GSE66862	1	Eed cKOvsWT
GSE69108	1	Nasal chondrocytevsRib Chondrocyte
GSE71565	1	differentiated for 12 daysvsdifferentiated for 5 days
GSE72261	1	Xbp1Cart{delta}Ex2 HZvsWt HZ
GSE72261	2	ColXN617K HZvsWt HZ
GSE72261	3	C/X HZvsWt HZ
GSE74898	1	cartilage, exercised for 2 daysvscartilage, control
GSE74898	2	cartilage, exercised for 5 daysvscartilage, control
GSE74898	3	cartilage, exercised for 15 daysvscartilage, control
GSE7683	1	DEX-treated embryonic primary chondrocyte cultures, incubated for 6vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 6
GSE7683	2	DEX-treated embryonic primary chondrocyte cultures, incubated for 24vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24
GSE78980	1	TO+/+ 1g no treatmentvsTO+/+ 0g no treatment
GSE78980	2	TO+/+ 1g treatedvsTO+/+ 1g no treatment
GSE78980	3	TO+/+ 0g treatedvsTO+/+ 0g no treatment
GSE78980	4	TO-/- 1g no treatmentvsTO-/- 0g no treatment
GSE78980	5	TO-/- 1g treatedvsTO-/- 1g no treatment
GSE78980	6	TO-/- 0g treatedvsTO-/- 0g no treatment
GSE78980	7	TO-/- 1g no treatmentvsTO+/+ 1g no treatment
GSE78980	8	TO-/- 0g no treatmentvsTO+/+ 0g no treatment
GSE78980	9	TO-/- 1g treatedvsTO+/+ 1g treated
GSE78980	10	TO-/- 0g treatedvsTO+/+ 0g treated
GSE79176	1	low (0.01mg/ml) concentration of polyphosphatesvsnone (control)
GSE79176	2	high (1mg/ml) concentration of polyphosphatesvsnone (control)
GSE79176	3	high (1mg/ml) concentration of polyphosphatesvslow (0.01mg/ml) concentration of polyphosphates
GSE81399	1	FACS sorted Dmp1-Cre targeted CAR cells from mouse bone marrowvsFACS sorted Dmp1-Cre non-targeted CAR cells from mouse bone marrow
GSE84609	1	X100.ng.ml.rGDF11vsVehicle.control
GSE84907	1	pH7.8vspH7.4
GSE84907	2	pH8.4vspH7.4
GSE84907	3	pH8.4vspH7.8
GSE85785	1	leptin-inducedvshealthy control
GSE90127	1	osteoblasts in differentiation medium and cabozantinib for 30 daysvsundifferentiated mouse osteoblasts
GSE90127	2	osteoblasts in differentiation medium and cabozantinib for 30 daysvsdifferentiated 30 day mouse osteoblasts
GSE90127	3	differentiated 30 day mouse osteoblastsvsundifferentiated mouse osteoblasts
GSE9247	1	MS-275 treated MC3T3 micevsDMSO treated MC3T3 mice
GSE9247	2	TSA treated MC3T3 micevsDMSO treated MC3T3 mice
GSE9247	3	VPA treated MC3T3 micevsDMSO treated MC3T3 mice
GSE99306	1	X13delChopKO_LHZvsWT_LHZ
GSE99306	2	X13delChopKO_LHZvsX13del_LHZ
GSE99306	3	X13del_LHZvsWT_LHZ
GSE99306	4	X13delChopKO_MHZvsX13del_MHZ
GSE99306	5	X13delChopKO_pHZvsWT_pHZ
GSE99306	6	X13delChopKO_pHZvsX13del_pHZ
GSE99306	7	X13del_pHZvsWT_pHZ
GSE99306	8	X13delChopKO_PZvsWT_PZ
GSE99306	9	X13delChopKO_PZvsX13del_PZ
GSE99306	10	X13del_PZvsWT_PZ
GSE99306	11	X13delChopKO_UHZvsWT_UHZ
GSE99306	12	X13delChopKO_UHZvsX13del_UHZ
GSE99306	13	X13del_UHZvsWT_UHZ
GSE99414	1	Il15ra nullvsCtrl
E-ERAD-89	1	MELATONIN_6vsDMSO_6
E-ERAD-89	2	MELATONIN_24vsDMSO_24
E-ERAD-89	3	SEROTONIN_24vsDMSO_24
E-ERAD-89	4	MELATONIN_48vsDMSO_48
E-GEOD-45893	1	Osr1MutvsOsr1WT
E-GEOD-53105	1	diaphysis_KOvsdiaphysis_WT
E-GEOD-53105	2	metaphysis_KOvsmetaphysis_WT
E-GEOD-54461	1	Day4vsDay2
E-GEOD-54461	2	Day6vsDay2
E-GEOD-54461	3	Day8vsDay2
E-GEOD-54461	4	Day10vsDay2
E-GEOD-54461	5	Day12vsDay2
E-GEOD-54461	6	Day14vsDay2
E-GEOD-54461	7	Day16vsDay2
E-GEOD-54461	8	Day18vsDay2
E-GEOD-73372	1	P1vsE18.5
E-GEOD-73372	2	P3vsE18.5
E-GEOD-73372	3	P3vsP1
E-GEOD-75549	1	hdac3KOvsWT
E-GEOD-76988	1	STAT5_cKOvsSTAT5_WT
E-MTAB-2923	1	osteoblastvsimmature_osteoblast
E-MTAB-2923	2	immature_osteoblastvsosteoprogenitor
E-MTAB-2923	3	osteoblastvsosteoprogenitor
E-MTAB-2923	4	osteoblastvsmesenchymal_stem_cell
E-MTAB-3428	1	KO-5AMvsWT-5AM
E-MTAB-3428	2	KO-5PMvsWT-5PM
E-MTAB-3428	3	KO-9AMvsWT-9AM
E-MTAB-3428	4	KO-9PMvsWT-9PM
GSE102856	1	Senp6-MutvsWT
GSE103492	1	WT_Wnt3avsWT
GSE103492	2	Lrp5KOvsWT
GSE103492	3	Lrp5KO_Wnt3avsWT
GSE103492	4	Lrp5KO_Wnt3avsLrp5KO
GSE103492	5	Lrp6_KOvsLrp6_Ctl
GSE103492	6	Lrp6KO_Wnt3avsLrp6_Ctl
GSE103492	7	Lrp6KO_Wnt3avsLrp6_KO
GSE103492	8	Lrp5_6_KOvsLrp5_6_Ctl
GSE103492	9	Lrp5_6_KO_Wnt3avsLrp5_6_Ctl
GSE103492	10	Lrp5_6_KO_Wnt3avsLrp5_6_KO
GSE106259	1	CCL5vsControl
GSE23492	1	Cell culture of isolated chondrocytes from growth plate cartilage, day 20 of differentiationvsNative growth plate cartilage
GSE23492	2	Cell culture of isolated chondrocytes from growth plate cartilage, day 10 of differentiationvsNative growth plate cartilage
GSE23492	3	Cell culture of isolated chondrocytes from articular cartilage, day 20 of differentiationvsNative articular cartilage
GSE23492	4	Cell culture of isolated chondrocytes from articular cartilage, day 10 of differentiationvsNative articular cartilage
GSE23492	5	Native articular cartilagevsNative growth plate cartilage
GSE44991	1	cartilage tissue from the condylus medialis femoris.affectedvscartilage tissue from the condylus medialis femoris.non-affected
GSE44991	2	cartilage tissue from the medial part of condylus humeri.affectedvscartilage tissue from the medial part of condylus humeri.non-affected
GSE39796	1	cartilage, superficial zonevscartilage, deep zone
GSE39796	2	cartilage, middle zonevscartilage, deep zone
GSE39796	3	cartilage, superficial zonevscartilage, middle zone
GSE18394	1	chondrocytes_day28vsMSC_day0
GSE18394	2	chondrocytes_day28vsMSC_day28
GSE18394	3	MSC_day28vsMSC_day0
GSE29233	1	TGFb treatedvsUntreated
E-MEXP-2291	1	nucleus pulposusvsarticular cartilage
E-MEXP-2291	2	annulus fibrosusvsarticular cartilage
E-MEXP-2291	3	nucleus pulposusvsannulus fibrosus
GSE110581	1	Zfp36l1 shRNA AdenovirusvsNull Control Adenovirus
GSE110581	2	Zfp36l1 AdenovirusvsNull Control Adenovirus
GSE47799	1	meniscusvsarticular cartilage
GSE47799	2	meniscusvscruciate ligament
GSE47799	3	cruciate ligamentvsarticular cartilage
E-MTAB-5879	1	Injury.Day7vsControl.Day0
E-MTAB-5879	2	Injury.Day28vsControl.Day0
E-MTAB-5879	3	InjuryReconstruct.Day7vsControl.Day0
E-MTAB-5879	4	InjuryReconstruct.Day28vsControl.Day0
E-MTAB-5879	5	InjuryRepair.Day7vsControl.Day0
E-MTAB-5879	6	InjuryRepair.Day28vsControl.Day0
E-MTAB-5879	7	InjuryRepair.Day28vsInjury.Day28
E-MTAB-5879	8	InjuryReconstruct.Day28vsInjury.Day28
E-MTAB-5879	9	InjuryRepair.Day7vsInjury.Day7
E-MTAB-5879	10	InjuryReconstruct.Day7vsInjury.Day7
E-MTAB-4294	1	synovitisvsControl
E-MTAB-4294	2	synovitis_with_corticosteroidvsControl
E-MTAB-4294	3	synovitis_with_corticosteroidvssynovitis
E-MTAB-3186	1	Day1vsControl
E-MTAB-3186	2	Day5vsControl
E-MTAB-3186	3	Day9vsControl
E-MTAB-3186	4	Day14vsControl
GSE110303	1	WT_PlbvsWT_E2
GSE110303	2	KO_PlbvsWT_Plb
GSE110303	3	KO_E2vsWT_E2
GSE110300	1	WT_PlbvsWT_E2
GSE110300	2	KO_PlbvsWT_Plb
GSE110300	3	KO_E2vsWT_E2
GSE110281	1	Sox9PosvsLrg5Pos
GSE110281	2	Sox9PosvsLrg5Neg
GSE110281	3	Lrg5PosvsLrg5Neg
GSE104459	1	E12.5_Pitx_KOvsE12.5WT
GSE104459	2	E11.5_Pitx_KOvsE11.5WT
GSE104459	3	E9.5_Pitx_KOvsE9.5WT
GSE110051	1	Mature_cartilagevsImmature_cartilage
GSE110051	2	BonevsMature_cartilage
GSE110051	3	BonevsImmature_cartilage
GSE111628	1	ovariectomizedvssham surgery
GSE111628	2	ovariectomized mice with treadmill trainingvsovariectomized
GSE111628	3	ovariectomized mice with treadmill trainingvssham surgery
GSE5657	1	Hyp malevsNormal male
GSE5657	2	Hyp femalevsNormal female
GSE13782	1	InflamedvsNormal
GSE41039	1	proteoglycan-induced spondylitisvsnone (Control)
GSE112694	1	Zfp384KO_3DayvsWT_3Days
GSE112694	2	Zfp384KO_7DayvsWT_7Days
GSE112694	3	WT_7DaysvsWT_3Days
GSE112694	4	Zfp384KO_7DayvsZfp384KO_3Day
GSE84198	1	Ezh2 KO proximal tibia PZvsWT proximal tibia PZ
GSE84198	2	Ezh2 KO proximal tibia HZvsWT proximal tibia HZ
GSE84198	3	WT proximal tibia PZvsWT proximal tibia HZ
GSE114469	1	Y1 deficient mousevsWT mouse
GSE108036	1	ANP32A KOvsWild.type
GSE97232	1	p21 misexpressionvsControl
GSE114079	1	SMAD3KO_E11.5vsWT_E11.5
GSE114079	2	SMAD3KO_E12.5vsWT_E12.5
GSE114079	3	SMAD3KO_E13.5vsWT_E13.5
GSE114079	4	SMAD3KO_E14.5vsWT_E14.5
GSE104828	1	Tet2KOvsWT
GSE114521	1	Sox9null_E11.5vsControl_E11.5
GSE114521	2	Sox9null_E12.5vsControl_E12.5
GSE112413	1	Mutant_SkullvsWT_Skull
GSE112413	2	WT_Cranial_BasevsWT_Skull
GSE101909	1	E14.5_Fgf8vsE14.5_Ctrl
GSE101909	2	E16.5_Fgf8vsE16.5_Ctrl
GSE114919	1	Phalanx_PZ_1wkvsPhalanx_HZ_1wk
GSE114919	2	Tibia_PZ_4wkvsTibia_PZ_1wk
GSE114919	3	Tibia_PZ_4wkvsTibia_HZ_4wk
GSE114919	4	Tibia_PZ_1wkvsTibia_HZ_1wk
GSE114919	5	Tibia_HZ_4wkvsTibia_HZ_1wk
GSE60451	1	TIMPlessvswild type
GSE47902	1	SHOX transgenevswildtype
GSE44325	1	Sost-/-; Sostdc1-/-vswild-type
GSE4481	1	R/P.CNP at 10exp(-6) MvsR/P.vehicle: BSA/HCL 1.0 Mm
GSE4481	2	H.CNP at 10exp(-6) MvsH.vehicle: BSA/HCL 1.0 Mm
GSE4481	3	M.CNP at 10exp(-6) MvsM.vehicle: BSA/HCL 1.0 Mm
GSE102292	1	15 daysvs12 days
GSE102292	2	12 daysvs9 days
GSE102292	3	9 daysvs6 days
GSE102292	4	6 daysvs2 days
GSE114919_Rat	1	Phalanx_PZ_1wkvsPhalanx_HZ_1wk
GSE114919_Rat	2	Tibia_PZ_4wkvsTibia_PZ_1wk
GSE114919_Rat	3	Tibia_PZ_4wkvsTibia_HZ_4wk
GSE114919_Rat	4	Tibia_PZ_1wkvsTibia_HZ_1wk
GSE114919_Rat	5	Tibia_HZ_4wkvsTibia_HZ_1wk
GSE41898	1	Lkb1 mutant micevscontrol mice
GSE18738	1	hypertrophic zonevsreserve zone
GSE87605	1	Hypertrophic cell layervsFlat cell layer
GSE87605	2	Flat cell layervsRound cell layer
GSE87605	3	Hypertrophic cell layervsRound cell layer
GSE16981	1	Hypertrophic zone.1 weekvsProliferative zone.1 week
GSE16981	2	Resting zone.1 weekvsProliferative zone.1 week
GSE16981	3	Hypertrophic zone.1 weekvsResting zone.1 week
GSE16981	4	Hypertrophic zone.1 weekvsResting zone.1 week
GSE16981	5	Proliferative and early hypertrophic zone.6weeksvsProliferative and early hypertrophic zone.3weeks
GSE16981	6	Proliferative and early hypertrophic zone.9weeksvsProliferative and early hypertrophic zone.6weeks
GSE16981	7	Proliferative and early hypertrophic zone.12weeksvsProliferative and early hypertrophic zone.9weeks
GSE29859	1	CorticalBone_ExcessVitAvsCorticalBone_Control
GSE29859	2	CorticalBone.Marrow_ExcessVitAvsCorticalBone.Marrow_Control
GSE104473	1	Mandibular Distraction_10_BCSPvsMandibular Fracture_10_BCSP
GSE104473	2	Mandibular Distraction_10_OPvsMandibular Fracture_10_OP
GSE104473	3	Mandibular Distraction_10_SSCvsMandibular Fracture_10_SSC
GSE104473	4	Mandibular Distraction_15_BCSPvsMandibular Fracture_15_BCSP
GSE104473	5	Mandibular Distraction_15_OPvsMandibular Fracture_15_OP
GSE104473	6	Mandibular Fracture_15_SSCvsMandibular Distraction_15_SSC
GSE121033	1	Lentiviruses expressing LucvsNon surgery
GSE121033	2	Lentiviruses expressing PC2vsNon surgery
GSE108721	1	WT_RANKLvsWT_Basal
GSE108721	2	Mir182Loss_BasalvsWT_Basal
GSE108721	3	Mir182Gain_BasalvsWT_Basal
GSE108721	4	Mir182Loss_RANKLvsWT_RANKL
E-MTAB-6417	1	bone marrow.fracturevsbone marrow.none
E-MTAB-6417	2	periosteum.fracturevsperiosteum.none
E-MTAB-6417	3	periosteum.fracturevsbone marrow.fracture
E-MTAB-6417	4	periosteum.nonevsbone marrow.none
GSE120308	1	P5 Xbp1 KOvsP5 Xbp1 WT
GSE120308	2	P5 Xbp1 WT Matn3 MUTvsP5 Xbp1 KO Matn3 MUT
GSE120308	3	P5 Xbp1 KO Matn3 MUTvsP5 Xbp1 KO
GSE120308	4	P5 Xbp1 WT Matn3 MUTvsP5 Xbp1 WT
GSE115084	1	Flcn targeted siRNA transfectedvsscramble siRNA transfected
E-GEOD-8488	1	LYvsDMSO
E-GEOD-8488	2	UO126vsDMSO
E-GEOD-8488	3	SB90vsDMSO
E-GEOD-8488	4	TSAvsDMSO
E-MTAB-6857	1	FournucleivsTwonuclei
GSE112641	1	Injured_MRL_MpJ_1_day_post_injuryvsUninjured_MRL_MpJ_1_day_post_injury
GSE112641	2	Injured_C57BL_6_1_day_post_injuryvsUninjured_C57BL_6_1_day_post_injury
GSE112641	3	Injured_STR_ort_1_day_post_injuryvsUninjured_STR_ort_1_day_post_injury
GSE112641	4	Injured_MRL_MpJ_1_week_post_injuryvsUninjured_MRL_MpJ_1_week_post_injury
GSE112641	5	Injured_C57BL_6_1_week_post_injuryvsUninjured_C57BL_6_1_week_post_injury
GSE112641	6	Injured_STR_ort_1_week_post_injuryvsUninjured_STR_ort_1_week_post_injury
GSE112641	7	Injured_MRL_MpJ_2_weeks_post_injuryvsUninjured_MRL_MpJ_2_weeks_post_injury
GSE112641	8	Injured_C57BL_6_2_weeks_post_injuryvsUninjured_C57BL_6_2_weeks_post_injury
GSE112641	9	Injured_STR_ort_2_weeks_post_injuryvsUninjured_STR_ort_2_weeks_post_injury
GSE120244	1	Cre recombinasevsGFP
GSE121029	1	Lentiviruses expressing WT DGCR8vsLentiviruses expressing Luc
GSE121029	2	Lentiviruses expressing mtDRBD DGCR8vsLentiviruses expressing Luc
GSE121887	1	osteoblastsvsbone
GSE123076	1	Adamts17-/-vswild type
GSE125153	1	Bcl3 knockout_1 dayvsWild-type_1 day
GSE125153	2	Bcl3 knockout_3 daysvsWild-type_3 days
GSE125153	3	Wild-type_3 daysvsWild-type_1 day
GSE125153	4	Bcl3 knockout_3 daysvsBcl3 knockout_1 day
GSE128402	1	Col2Cre; Adgrg6f/fvswild type
GSE135282	1	Piezo1KOvsWT
GSE7685	1	Manually.microdissected.embryonic.tibiae..zone.I.of.growth.platevsManually.microdissected.embryonic.tibiae..zone.II.of.growth.plate
GSE7685	2	Manually.microdissected.embryonic.tibiae..zone.II.of.growth.platevsManually.microdissected.embryonic.tibiae..zone.III.of.growth.plate
GSE7685	3	Manually.microdissected.embryonic.tibiae..zone.I.of.growth.platevsManually.microdissected.embryonic.tibiae..zone.III.of.growth.plate
GSE97828	1	MUTvsWT
GSE98295	1	miR-140 WT/G heterovsmiR-140 WT
GSE98295	2	miR-140 G/GvsmiR-140 WT
GSE98295	3	miR-140 KOvsmiR-140 WT
GSE141820	1	Kdm6DKOvsWT
GSE137899	1	IWR-1vsDMSO
GSE137899	2	XAV939vsDMSO
GSE137899	3	siTnks/2vssiCtrl
GSE134768	1	mutantvscontrol
GSE75995	1	Mouse chondrocyte pellet culture in the absence of pterosin BvsMouse chondrocyte pellet culture in the presence of pterosin B
GSE128490	1	LG/JvsSM/J
GSE132894	1	CRY2-KOvsWT
GSE128093	1	rat knee joints treated with BNTAvsrat knee joints treated with normal saline
GSE125320	1	Lentiviruses expressing CBX4vsLentiviruses expressing Luc
GSE125320	2	Lentiviruses expressing LucvsNon surgery
GSE123130	1	Col2a1Cre;Idh1 fl/+vsCol2a1Cre
GSE126846	1	miR-204 transfectionvsmiR-Ctrl transfection
GSE147529	1	KO_Sham_2wvsWT_Sham_2w
GSE147529	2	KO_Sham_4wvsWT_Sham_4w
GSE147529	3	KO_DMM_2wvsWT_DMM_2w
GSE147529	4	KO_DMM_4wvsWT_DMM_4w
GSE144265	1	Fluid Flow Shear Stress (FFSS)_HDAC4 and HDAC5 deletion cellsvsFluid Flow Shear Stress (FFSS)_original cells
GSE144265	2	STATIC_HDAC4 and HDAC5 deletion cellsvsSTATIC_original cells
GSE141308	1	exposed.to.cartilage.fragmentsvscontrol
GSE123985	1	OBs_d14_biologicalvsOBs_d10_biological
GSE146349	1	A2AR KOvsWT
GSE146813	1	Lipo-CGSvsLiposome
GSE146813	2	LiposomevsUninvolved knee
GSE121780	1	Apert syndrome_mandibular bonevscontrol_mandibular bone
GSE121780	2	Apert syndrome_Meckel's cartilagevscontrol_Meckel's cartilage
GSE121780	3	Apert syndrome_mandibular condylar cartilagevscontrol_mandibular condylar cartilage
GSE110268_3	1	ACLT and FOXD1vsACLT and Luciferase
GSE110268_3	2	ACLT and Luciferasevsno treatment
GSE110268_3	3	ACLT and YAPvsACLT and Luciferase
GSE112318	1	mBMSC_2_weekvsmBMSC_0_week
GSE113982	1	p2_Proliferative zonevsp2_Hypertrophic zone
GSE113982	2	p2_Resting zonevsp2_Hypertrophic zone
GSE113982	3	p2_Proliferative zonevsp2_Resting zone
GSE113982	4	p28_Proliferative zonevsp28_Hypertrophic zone
GSE113982	5	p28_Resting zonevsp28_Hypertrophic zone
GSE113982	6	p28_Proliferative zonevsp28_Resting zone
GSE117643	1	Irx5KOvsWT
GSE118559	1	Î±Klotho and sTGFBR2vsnone (SHAM)
GSE118559	2	none (OAC)vsnone (SHAM)
GSE126969	1	Hes1derived CAR cellsvsFgfr3derived CAR cells
GSE133212	1	Ctrl_loaded R sidevsCtrl_non-loaded L side
GSE133212	2	NT3-Cre+_non-loaded L sidevsCtrl_non-loaded L side
GSE133212	3	NT3-Cre+_loaded R sidevsCtrl_loaded R side
GSE135865	1	Wildtype_MDA PCa 2b-conditioned mediumvsWildtype_Unconditioned medium
GSE135865	2	F2rl1KO_MDA PCa 2b-conditioned mediumvsF2rl1KO_Unconditioned medium
GSE135865	3	F2rl1KO_Unconditioned mediumvsWildtype_Unconditioned medium
GSE138980	1	B-Catenin siRNA and 5uM GSK126vsnon-targeting siRNA and 5uM GSK126
GSE138980	2	non-targeting siRNA and 5uM GSK126vsnon-targeting siRNA
GSE138980	3	B-Catenin siRNA and 5uM GSK126vsnon-targeting siRNA
GSE139907	1	induced osteoblastvscalvarial progeniter cell
GSE139907	2	GFP sorted from induced osteoblastvsGFP sorted from bone chip
GSE141686	1	NU7441vsDMSO
GSE152986	1	siStat3 at 24 hours and DMSO 24 hours latervssiScramble at 24 hours and DMSO 24 hours later
GSE152986	2	siStat3 at 24 hours and RANKL 24 hours latervssiScramble at 24 hours and RANKL 24 hours later
GSE152986	3	siScramble at 24 hours and RANKL 24 hours latervssiScramble at 24 hours and DMSO 24 hours later
GSE151332	1	NU7441vsDMSO
GSE141743	1	ADAM10 flox/flox-Col2a1-Crevscontrol
GSE140785	1	DRG DMM+4wkvsDRG sham+4wk
GSE140785	2	DRG DMM+16wkvsDRG sham+16wk
GSE136198	1	Normal_plusvsNormal_minus
GSE136198	2	Microtia_plusvsMicrotia_minus
GSE136198	3	Microtia_minusvsNormal_minus
GSE130191	1	CreTWvsCre
GSE127956	1	Wisp1 KOvsWT
GSE119523	1	PF sutures of Runx2+/+ at P7vsPF sutures of Runx2+/+ at P5
GSE119523	2	PF sutures of Runx2+/â at P7vsPF sutures of Runx2+/+ at P7
GSE118640	1	Hox13dKO autopod at E11.25vsWild type autopod at E11.25
GSE106965	1	Hif1a knockdown chondrocytesvsControl chondrocytes
GSE103159	1	24 hrs after the loadingvsbefore the loading
GSE46400	1	osteoblast inductionvsnone
GSE157180	1	Articular Chondrocytes 12w MLIIIvsArticular Chondrocytes 12w WT
GSE155892	1	K9-4HvsWT-4H
GSE155892	2	WT-4HvsWT-CTR
GSE155892	3	K9-4HvsK9-CTR
GSE155892	4	K9-CTRvsWT-CTR
GSE155896	1	MAPK9 KOvsWT
GSE154949	1	treatment_3_weeksvstreatment_1_week
GSE105121	1	TET1KOvsTET1WT
GSE150352	1	control_midshaftvscontrol_end
GSE150352	2	H3.3K36M_midshaftvsH3.3K36M_end
GSE150352	3	H3.3K36M_midshaftvscontrol_midshaft
GSE150352	4	H3.3K36M_endvscontrol_end
GSE160364	1	LRCsvsNon-LRCs
GSE157433	1	Cntl_SFZ chondrocytesvsCntl_DZ chondrocytes
GSE157433	2	Runx3cKO_SFZ chondrocytesvsRunx3cKO_DZ chondrocytes
GSE157433	3	Runx3cKO_SFZ chondrocytesvsCntl_SFZ chondrocytes
GSE157433	4	Runx3cKO_DZ chondrocytesvsCntl_DZ chondrocytes
GSE144360	1	Mir140-nullvswild-type control
GSE116628	1	Wnt7b overexpressionvscontrol
GSE155435	1	10uM BPDP_3 hoursvsDMSO_3 hours
GSE155435	2	1uM BPDP_3 hoursvsDMSO_3 hours
GSE155435	3	10uM BPDP_24 hoursvsDMSO_24 hours
GSE155435	4	1uM BPDP_24 hoursvsDMSO_3 hours
GSE147833	1	mRNA_4_IL1vsmRNA_4_0
GSE147833	2	mRNA_4_TNFvsmRNA_4_0
GSE147833	3	mRNA_12_IL1vsmRNA_12_0
GSE147833	4	mRNA_12_TNFvsmRNA_12_0
GSE147833	5	mRNA_24_IL1vsmRNA_24_0
GSE147833	6	mRNA_24_TNFvsmRNA_24_0
GSE147833	7	mRNA_72_IL1vsmRNA_72_0
GSE147833	8	mRNA_72_TNFvsmRNA_72_0
E-MTAB-7430	1	TNF-alpha (0.6 nanomole per liter)vsnone
E-MTAB-7430	2	recombinant human CCL25 (5 nanomole per liter)vsnone
E-MTAB-7430	3	recombinant human CCL25 (500 nanomole per liter)vsnone
E-MTAB-7430	4	recombinant human CCL25 (5 nanomole per liter); TNF-alpha (0.6 nanomole per liter)vsnone
E-MTAB-7430	5	recombinant human CCL25 (500 nanomole per liter); TNF-alpha (0.6 nanomole per liter)vsnone
GSE105256	1	WT RoundvsWT Columnar/Hypertrophic
GSE133775	1	MiR34aKOvswild_type
GSE135392	1	beta_actin_wild_type_Day_14vsbeta_actin_wild_type_Day_4
GSE135392	2	beta_actin_knockout_Day_14vsbeta_actin_knockout_Day_4
GSE135392	3	beta_actin_knockout_Day_4vsbeta_actin_wild_type_Day_4
GSE135392	4	beta_actin_knockout_Day_14vsbeta_actin_wild_type_Day_14
GSE135392	5	beta_actin_heterozygote_Day_14vsbeta_actin_wild_type_Day_14
GSE135984	1	X10ng_per_ml_BMP2_day 1vsVehicle_day 1
GSE135984	2	X50ng_per_ml_BMP2_day 1vsVehicle_day 1
GSE135984	3	X5microM_GSK126_day 1vsVehicle_day 1
GSE135984	4	X10ng_per_ml_BMP2__5microM_GSK126_day 1vsVehicle_day 1
GSE135984	5	X50ng_per_ml_BMP2__5microM_GSK126_day 1vsVehicle_day 1
GSE135984	6	X10ng_per_ml_BMP2_day 6vsVehicle_day 6
GSE135984	7	X50ng_per_ml_BMP2_day 6vsVehicle_day 6
GSE135984	8	X5microM_GSK126_day 6vsVehicle_day 6
GSE135984	9	X10ng_per_ml_BMP2__5microM_GSK126_day 6vsVehicle_day 6
GSE135984	10	X50ng_per_ml_BMP2__5microM_GSK126_day 6vsVehicle_day 6
GSE145019	1	joints of aged mice injected with lentivirus expressing CLOCKvsjoints of aged mice injected with lentivirus expressing Luc
GSE145821	1	Mutant mouse at 4wkvsControl littermate mouse at 4wk
GSE145821	2	Mutant mouse at 3wkvsControl littermate mouse at 3wk
GSE145821	3	Mutant mouse at 2wkvsControl littermate mouse at 2wk
GSE145821	4	Mutant mouse at 1wkvsControl littermate mouse at 1wk
GSE153179	1	Ad-shRegnase-1 infectedvsAd-null infected
GSE153179	2	Ad-Regnase-1 infectedvsAd-null infected
GSE154381	1	Sox9fl_flAcanCreERGP7days__Growth_plate_cartilagevsSox9fl_flGP7days__Growth_plate_cartilage
GSE154381	2	Sox9fl_flAcanCreERAC14days__Articular_cartilagevsSox9fl_flAC14days__Articular_cartilage
GSE154381	3	Sox9fl_flAcanCreERGP14days__Growth_plate_cartilagevsSox9fl_flGP14days__Growth_plate_cartilage
GSE154381	4	Sox8fl_flSox9fl_flAcanCreERAC14days__Articular_cartilagevsSox8fl_flSox9fl_flAC14days__Articular_cartilage
GSE154381	5	Sox8fl_flSox9fl_flAcanCreERGP14days__Growth_plate_cartilagevsSox8fl_flSox9fl_flGP14days__Growth_plate_cartilage
GSE155118	1	Sox5_6_9_OEvscontrol
GSE158452	1	mutantvscontrol
GSE162266	1	three.p.seed.region.mutationvswildtype.for.the.CG.mutants
GSE162266	2	CT.base.changevswildtype.for.the.CT.mutant
GSE162823	1	Femoral condylar cartilage (FCC)vsHypertrophic chondrocytes Zone (HZ) of mandibular condylar cartilage (MCC)
GSE162823	2	Fibrous Zone (FZ) of mandibular condylar cartilage (MCC)vsHypertrophic chondrocytes Zone (HZ) of mandibular condylar cartilage (MCC)
GSE162823	3	Proliferative Zone (PZ) of mandibular condylar cartilage (MCC)vsHypertrophic chondrocytes Zone (HZ) of mandibular condylar cartilage (MCC)
GSE162823	4	Mature chondrocytes Zone (MZ) of mandibular condylar cartilage (MCC)vsHypertrophic chondrocytes Zone (HZ) of mandibular condylar cartilage (MCC)
GSE163080_Rat	1	rat_modelvsrat_control
GSE163080	1	mouse_modelvsmouse_control
GSE164835	1	FMKvsDMSO
GSE164835	2	OPHvsDMSO
GSE165084	1	KO_ControlvsWT_Control
GSE165084	2	WT_IL1BvsWT_Control
GSE165084	3	KO_IL1BvsKO_Control
GSE165219	1	RIP1vscontrol
GSE165951	1	Foxc1_2_DKOvswild_type
GSE168303	1	SBPvsunstimulated
GSE171420	1	macrophages_activated_by_cartilage_fragmentsvscontrol
GSE173637	1	Dysplasiavscontrol
GSE174323	1	MiglustatvsControl
GSE174323	2	D-PDMPvsControl
GSE174323	3	D-PPMPvsControl
GSE175486	1	DMMvscontrol
GSE176265	1	BMMs_RANKL_24hvsBMMs_RANKL_0h
GSE176265	2	BMMs_RANKL_48hvsBMMs_RANKL_0h
GSE176265	3	BMMs_RANKL_72hvsBMMs_RANKL_0h
GSE178090	1	Eldr_cKOvscontrol
GSE178091	1	Eldr_cKIvscontrol
GSE178288	1	Runx2_cHom_KOvsRunx2_cHet_KO
GSE179174	1	TomatovsNonTomato
GSE179535	1	Sephs1_siRNA_transfectionvscontrol_siRNA_transfection
GSE181883	1	Creb5_TGFalpha_and_TGFÎ²2vsScramble_shRNA_TGFalpha_and_TGFÎ²2
GSE181883	2	Scramble_shRNA_TGFalpha_and_TGFÎ²2vsScramble_shRNA_TGFalpha
GSE181883	3	Creb5_TGFalphavsScramble_shRNA_TGFalpha
GSE182097	1	osteoclast precursors treated by CT-26 CMvsosteoclast precursors treated by normal culture medium
GSE182640	1	Hbb_conditional_knockout_in_chondrocytesvswildtype
GSE186501	1	high_shear_stress_treatmentvsuntreated
GSE186990	1	IL1_treatedvsuntreated
GSE190184	1	shGpx4vsshNC
GSE191024	1	cocultured_with_BMSCsvscultured_alone
GSE191175	1	Inner.LoadedvsInner.Unloaded
GSE191175	2	Inner.Loaded.IL1vsInner.Unloaded
GSE191175	3	Inner.Loaded.IL1vsInner.Unloaded.IL1
GSE191175	4	Outer.LoadedvsOuter.Unloaded
GSE191175	5	Outer.Loaded.IL1vsOuter.Unloaded
GSE191175	6	Outer.Loaded.IL1vsOuter.Unloaded.IL1
GSE192933	1	Girk3_KOvsWT
GSE192971	1	LDH_KOvsLDH
GSE192971	2	Acly_KOvsAcly
GSE197283	1	CKOvsWT
GSE198836	1	STZ_injectedvsControl
GSE199189	1	CRELD2_overexpressionvsControl
GSE200522	1	ablated_Lef1_levelsvsnormal_Lef1_levels
GSE200522	2	ablated_Sirt1_levelsvsnormal_Lef1_levels
GSE212315	1	Day85vsDay45
GSE214077	1	NG2_CSPG4KOvsWT
GSE26475	1	Murine knee joint_Operated (DMM)_6hrvsMurine knee joint_Operated (Sham)_6hr
GSE26475	2	Murine knee joint_Operated (DMM)_7daysvsMurine knee joint_Operated (Sham)_7days
GSE26475	3	Murine knee joint_Operated (DMM)_3dayvsMurine knee joint_Operated (Sham)_3day
GSE26475	4	Murine knee joint_Operated (DMM)_6hrvsMurine knee joint_Naive_0hr
GSE26475	5	Murine knee joint_Operated (DMM)_3dayvsMurine knee joint_Naive_0hr
GSE26475	6	Murine knee joint_Operated (DMM)_7daysvsMurine knee joint_Naive_0hr
GSE26475	7	Murine knee joint_Operated (Sham)_7daysvsMurine knee joint_Naive_0hr
GSE61855	1	ATDC5 day 15 Tet1vsATDC5 day 15 NT
GSE82285	1	WT Osteoblasts from 8 week old micevsWT Osteo-progenitors from 8 week old mice
GSE82285	2	WT Osteoblasts from 5 week old micevsWT Osteo-progenitors from 5 week old mice
GSE82285	3	WT Osteo-progenitors from 8 week old micevsWT Osteo-progenitors from 5 week old mice
GSE82285	4	WT Osteoblasts from 8 week old micevsWT Osteoblasts from 5 week old mice
GSE93418	1	Zac1_biallelic_expressing_Tongue_Embryonic_day_E13.5vswild_type_Tongue_Embryonic_day_E13.5
GSE93418	2	Zac1_biallelic_expressing_Tongue_Postnatal_day_P0vswild_type_Tongue_Postnatal_day_P0
GSE93418	3	Zac1_biallelic_expressing_Tongue_Postnatal_day_P20vswild_type_Tongue_Postnatal_day_P20
GSE93418	4	Zac1_biallelic_expressing_Costal_Chondrocytes_Embryonic_day_E18.5vswild_type_Costal_Chondrocytes_Embryonic_day_E18.5
GSE106131	1	Morphant_TCDDvsMorphant_DMSO
GSE106131	2	Control_TCDDvsControl_DMSO
GSE106131	3	Morphant_DMSOvsControl_DMSO
GSE106131	4	Morphant_TCDDvsControl_TCDD
GSE143249	1	Jab1 chondrocyte-specific knockout vsWild-type primary chondrocytes
GSE15069	1	LY294002-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
GSE15069	2	SB202190-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
GSE15069	3	TSA-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
GSE15069	4	UO126-treated embryonic primary chondrocyte cultures, incubated for 24hrs.vsDMSO-treated embryonic primary chondrocyte cultures, incubated for 24hrs.
GSE206513	1	Sirt6 cKOvswild type
GSE207148	1	CTGF_TGF treatmentvsControl
GSE207148	2	Docetaxel treatmentvsControl
GSE210743	1	Recombinant Sparcl1 proteinvscontrol
GSE221957	1	MIA vehiclevscontralateral vehicle
GSE221957	2	MIA inhibitorvsMIA vehicle
GSE221957	3	contralateral inhibitorvscontralateral vehicle
